Search details
1.
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer.
Nature
; 600(7888): 319-323, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34819663
2.
Phase III study of bilayer sustained-release tramadol tablets in patients with cancer pain: a double-blind parallel-group, non-inferiority study with immediate-release tramadol capsules as an active comparator.
Support Care Cancer
; 32(1): 69, 2023 Dec 29.
Article
in English
| MEDLINE | ID: mdl-38157081
3.
Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data.
Int J Clin Oncol
; 28(1): 69-78, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36357710
4.
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801.
Int J Clin Oncol
; 27(7): 1139-1144, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35534642
5.
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027.
BMC Cancer
; 21(1): 208, 2021 Mar 01.
Article
in English
| MEDLINE | ID: mdl-33648453
6.
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.
Jpn J Clin Oncol
; 51(8): 1269-1276, 2021 Aug 01.
Article
in English
| MEDLINE | ID: mdl-34115855
7.
A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401.
Support Care Cancer
; 29(9): 5237-5244, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-33649919
8.
Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.
Oncologist
; 25(4): e668-e674, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31771990
9.
Cold agglutinin-induced acrocyanosis without hemolytic anemia.
Ann Hematol
; 103(2): 681-683, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37940715
10.
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study.
BMC Cancer
; 18(1): 1231, 2018 Dec 10.
Article
in English
| MEDLINE | ID: mdl-30526545
11.
A Case of Dupilumab-Induced Diffuse Alveolar Hemorrhage.
Intern Med
; 2024 May 16.
Article
in English
| MEDLINE | ID: mdl-38749726
12.
Spontaneous regression of multiple solitary plasmacytoma harboring Epstein-Barr virus: a case report and literature review.
Int J Hematol
; 2024 Apr 15.
Article
in English
| MEDLINE | ID: mdl-38619657
13.
Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study.
J Cancer Res Clin Oncol
; 150(2): 89, 2024 Feb 12.
Article
in English
| MEDLINE | ID: mdl-38347279
14.
A case of synovitis-acne-pustulosis-hyperostosis-osteitis syndrome with right pleural effusion.
Respir Med Case Rep
; 46: 101927, 2023.
Article
in English
| MEDLINE | ID: mdl-37841283
15.
Benefit of prednisolone alone in nodal peripheral T-cell lymphoma with T follicular helper phenotype.
J Clin Exp Hematop
; 63(1): 37-42, 2023.
Article
in English
| MEDLINE | ID: mdl-36990775
16.
A case of successful desensitization treatment with tepotinib after tepotinib-induced rash.
Respir Med Case Rep
; 45: 101911, 2023.
Article
in English
| MEDLINE | ID: mdl-37706029
17.
Safety of anti-SARS-CoV-2 messenger RNA vaccine in lung cancer patients undergoing anticancer chemotherapy: A multicenter, prospective, observational, patient-reported outcome study.
Thorac Cancer
; 14(3): 231-236, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36404396
18.
Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia study.
Lung Cancer
; 176: 103-111, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36634571
19.
A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan.
JTO Clin Res Rep
; 4(5): 100508, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37250506
20.
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations.
Lung Cancer
; 184: 107349, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37651927